speb/financial-data huggingface dataset:
ADN1.DE income_statement (quarterly, 2025-09-30) — +Total Revenue: 374599000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 63389000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 184017000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 43588000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 44878000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -6979000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 187648000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 6528000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 45173000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 49203000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Cash Financial: 45173000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5122000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -6978000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 361000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Common Stock: 6528000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 191135000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 300285000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Current Assets: 427047000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 40108000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 40108000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 328684000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Current Provisions: 9071000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Depreciation: 19426000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 19426000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 19426000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 19426000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 11997000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — EBIT: 20777000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — EBITDA: 40203000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -66000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — End Cash Position: 45173000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -20092000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 21393000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Goodwill: 100156000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 140495000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 230084000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Gross Profit: 74314000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Interest Expense: 3314000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3314000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Interest Income: 539000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 539000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -2997000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 218000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 191135000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7919000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 25371000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 147540000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 147540000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3205000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 2830000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3258000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Minority Interests: -174000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -15000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 304000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income: 11997000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 11997000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 12171000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 11997000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 11997000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 17463000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 12171000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -3363000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -2775000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1143000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -2775000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -7374000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 230084000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3616000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 50640000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 24321000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3220000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 16142000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 40762000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 12386600.24
ADN1.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 28372000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Operating Income: 21890000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 374599000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 6407129.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 28541000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 159476000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 40339000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3200000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 923000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 35796000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Properties: 230084000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 153957000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 4030000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Payables: 72913000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 17463000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -15000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -3363000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -1196000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3616000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 300285000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 19426000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 151008000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 53000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 6528220.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Special Income Charges: -486000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 191135000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 50640000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -169399.76
ADN1.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 5292000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 11329000.00
ADN1.DE cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -6024000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 851446000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 191135000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 187648000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 194393000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 352709000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 657053000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 424399000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 328369000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 9524000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -559000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -559000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (quarterly, 2025-09-30) — Working Capital: 98363000.00
ADN1.DE income_statement (quarterly, 2025-09-30) — Write Off: 486000.00
ADN1.DE income_statement (annual, 2025-12-31) — +Operating Expense: 378167000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — +Operating Expense: 219080000.00
ADN1.DE income_statement (annual, 2025-12-31) — +Total Revenue: 1465782000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 381674000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Accounts Payable: 64700000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 64700000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 213852000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 213852000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -77067000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -77067000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 39130000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 39130000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 15975000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 15975000.00
ADN1.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 6403521.00
ADN1.DE income_statement (annual, 2025-12-31) — Basic EPS: 2.83
ADN1.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 89682000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 45173000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 138794000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 138794000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -42409000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -19417000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 188417000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 188417000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 6522000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 84574000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 84574000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 89155000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 89155000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -5072000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Cash Financial: 84574000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 84574000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -23410000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 59400000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: -23079000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 59160000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Changes In Cash: -4686000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 39444000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Common Stock: 6522000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 6522000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -5072000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 189693000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 189693000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 304000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
ADN1.DE cash_flow (annual, 2025-12-31) — Common Stock Payments: -1844000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
ADN1.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 1038779000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 138768000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Assets: 412644000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 412644000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 41170000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 41170000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Debt: 2449000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 2449000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 43619000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 43619000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 327374000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 327374000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Current Provisions: 8882000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 8882000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Depreciation: 73010000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Depreciation: 18555000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 73010000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 18555000.00
ADN1.DE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 73010000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 18555000.00
ADN1.DE income_statement (annual, 2025-12-31) — Depreciation Income Statement: 73010000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 18555000.00
ADN1.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 6403738.00
ADN1.DE income_statement (annual, 2025-12-31) — Diluted EPS: 2.83
ADN1.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 18147000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 11811000.00
ADN1.DE income_statement (annual, 2025-12-31) — EBIT: 49953000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — EBIT: 27572000.00
ADN1.DE income_statement (annual, 2025-12-31) — EBITDA: 122963000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — EBITDA: 46127000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -422000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -43000.00
ADN1.DE cash_flow (annual, 2025-12-31) — End Cash Position: 84574000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 84574000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -43386000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -40652000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 43150000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 82005000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -32000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 0.00
ADN1.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 409000.00
ADN1.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 12229000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Goodwill: 100285000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 100285000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 163392000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 163392000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 306537000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 306537000.00
ADN1.DE income_statement (annual, 2025-12-31) — Gross Profit: 427003000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 242906000.00
ADN1.DE income_statement (annual, 2025-12-31) — Interest Expense: 13569000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 4129000.00
ADN1.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 13569000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4129000.00
ADN1.DE income_statement (annual, 2025-12-31) — Interest Income: 2060000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Interest Income: 669000.00
ADN1.DE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2060000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 669000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Interest Paid Cff: -11778000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -3149000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Interest Received Cfi: 1018000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 417000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 332412000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 332412000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -46859000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -21326000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 15975000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 15975000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 304000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 147247000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 147247000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 140270000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 140270000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 287517000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 287517000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 3052000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 3052000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 2205000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 2205000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 42494000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 42494000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Minority Interest: 3007000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 3007000.00
ADN1.DE income_statement (annual, 2025-12-31) — Minority Interests: 687000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Minority Interests: 565000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1663000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -8000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1540000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Net Debt: 58145000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 58145000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income: 18147000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income: 11811000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 18147000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 11811000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 17460000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 11246000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 18147000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 11811000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 18147000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 11811000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 36384000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 23443000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 17460000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 11246000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -28887000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -16080000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Interest Income: -11509000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -3460000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -4345000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2858000.00
ADN1.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -11509000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3460000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 16689000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -26381000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Net PPE: 229470000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 229470000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -12982000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -2797000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 26301000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 26301000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 14285000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 14285000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 12099000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 12099000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3187000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 3187000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 9904000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 9904000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 1537000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 1537000.00
ADN1.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 123641000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 45284000.00
ADN1.DE income_statement (annual, 2025-12-31) — Normalized Income: 18723300.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 11094450.00
ADN1.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 85559000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 101422000.00
ADN1.DE income_statement (annual, 2025-12-31) — Operating Income: 48836000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Operating Income: 23826000.00
ADN1.DE income_statement (annual, 2025-12-31) — Operating Revenue: 1465782000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 381674000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 6407129.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 6407129.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: 27974000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 27974000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 23317000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 23317000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 63107000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 63107000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 14380000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3502000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 875000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 875000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 6000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 6000.00
ADN1.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 114096000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -776000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Properties: 125249000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Properties: 125249000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 72778000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 72778000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 4581000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4581000.00
ADN1.DE income_statement (annual, 2025-12-31) — Other Special Charges: -796000.00
ADN1.DE income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Payables: 114389000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Payables: 114389000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 109947000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 109947000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 51000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 51000.00
ADN1.DE income_statement (annual, 2025-12-31) — Pretax Income: 36384000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 23443000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Properties: 0.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ADN1.DE cash_flow (annual, 2025-12-31) — Purchase Of Business: -1663000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -8000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -28887000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -16080000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -7934000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2993000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -13522000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -3337000.00
ADN1.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1038779000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 138768000.00
ADN1.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 73010000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 18555000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1844000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 154273000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 154273000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 3589000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 135000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 540000.00
ADN1.DE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 15391000.00
ADN1.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 27620000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Share Issued: 6528220.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 6528220.00
ADN1.DE income_statement (annual, 2025-12-31) — Special Income Charges: -485000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Special Income Charges: 886000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 189693000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 189693000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 26301000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 26301000.00
ADN1.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -101700.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 126450.00
ADN1.DE income_statement (annual, 2025-12-31) — Tax Provision: 18924000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 12197000.00
ADN1.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
ADN1.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
ADN1.DE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 8834000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 8834000.00
ADN1.DE cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -18178000.00
ADN1.DE cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -3621000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Assets: 848295000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 848295000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 329963000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 329963000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Debt: 331136000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 331136000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 192700000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 192700000.00
ADN1.DE income_statement (annual, 2025-12-31) — Total Expenses: 1416946000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 357848000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 655595000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 655595000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 435651000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 435651000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 328221000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 328221000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 49689000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 49689000.00
ADN1.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -678000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: 843000.00
ADN1.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -678000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 843000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (annual, 2025-12-31) — Working Capital: 85270000.00
ADN1.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 85270000.00
ADN1.DE income_statement (annual, 2025-12-31) — Write Off: 1281000.00
ADN1.DE income_statement (quarterly, 2025-12-31) — Write Off: -90000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 54731000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 398091000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 62238000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 196644000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 39358000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 6528220.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 0.39
ADN1.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 84574000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -9545000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 198170000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6528000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 54571000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 57730000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -65945000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -66502000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -30080000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 6528000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 193264000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 333714000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 442464000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 40758000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 40758000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 348111000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 8058000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 17837000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 17837000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 17837000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 17837000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 6528220.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.39
ADN1.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2485000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — EBIT: 9129000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — EBITDA: 26966000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 77000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 54571000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 23019000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -53428000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 101018000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 167666000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 238385000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 64377000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 3141000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3141000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Interest Income: 468000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 468000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -2783000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 121000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 193264000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -9216000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 27127000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 157412000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 157412000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2933000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 2254000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 3074000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Minority Interests: -192000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -448000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income: 2485000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2485000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2677000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2485000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2485000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 5988000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2677000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -6709000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -2673000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 656000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -2673000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 37235000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 238385000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2836000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 25598000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 14333000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 13208000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2748000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 10157000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 27499000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 2804800.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -43883000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Operating Income: 9646000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 398091000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 6407129.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 32268000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 161993000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 66648000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 3591000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1001000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 41001000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Properties: 238385000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Receivables: 146152000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3159000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Payables: 74417000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 5988000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -448000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -6709000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1026000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2836000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 333714000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 17837000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 156719000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1682000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 6528220.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -533000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 193264000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 25598000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -213200.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 3311000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 9670000.00
ADN1.DE cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -5249000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 892784000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 193264000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 198170000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 196338000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 388445000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 696446000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 450320000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 348335000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 12179000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -533000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -533000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 121091.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 9998000.00
ADN1.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 94353000.00
ADN1.DE income_statement (quarterly, 2026-03-31) — Write Off: 533000.00
ADNT balance_sheet (annual, 2021-09-30) — Assets Held For Sale Current: 49000000.00
ADNT cash_flow (annual, 2021-09-30) — Change In Other Working Capital: -136000000.00
ADNT balance_sheet (annual, 2021-09-30) — Current Provisions: 115000000.00
ADNT cash_flow (annual, 2021-09-30) — Gain Loss On Investment Securities: 30000000.00
ADNT cash_flow (annual, 2021-09-30) — Gain Loss On Sale Of Business: 26000000.00
ADNT income_statement (annual, 2021-09-30) — Gain On Sale Of Business: -26000000.00
ADNT income_statement (annual, 2021-09-30) — Gain On Sale Of Security: -30000000.00
ADNT cash_flow (annual, 2021-09-30) — Net Investment Purchase And Sale: -12000000.00
ADNT cash_flow (annual, 2021-09-30) — Net Other Investing Changes: 15000000.00
ADNT cash_flow (annual, 2021-09-30) — Other Cash Adjustment Outside Changein Cash: -16000000.00
ADNT balance_sheet (annual, 2021-09-30) — Preferred Securities Outside Stock Equity: 240000000.00
ADNT cash_flow (annual, 2021-09-30) — Purchase Of Investment: -12000000.00
ADNT income_statement (annual, 2021-09-30) — Salaries And Wages: -24000000.00
ADNT cash_flow (annual, 2021-09-30) — Sale Of Business: 785000000.00
ADNT income_statement (annual, 2021-09-30) — Selling And Marketing Expense: 537000000.00
ADNT income_statement (annual, 2022-09-30) — +Operating Expense: 598000000.00
ADNT income_statement (annual, 2022-09-30) — +Total Revenue: 14121000000.00
ADNT balance_sheet (annual, 2022-09-30) — Accounts Payable: 2478000000.00
ADNT balance_sheet (annual, 2022-09-30) — Accounts Receivable: 1852000000.00
ADNT balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -2793000000.00
ADNT balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 4026000000.00
ADNT balance_sheet (annual, 2022-09-30) — Allowance For Doubtful Accounts Receivable: -21000000.00
ADNT cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 52000000.00
ADNT cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 52000000.00
ADNT cash_flow (annual, 2022-09-30) — Asset Impairment Charge: 10000000.00
ADNT balance_sheet (annual, 2022-09-30) — Assets Held For Sale Current: 0.00
ADNT income_statement (annual, 2022-09-30) — Basic Average Shares: 94858156.00
ADNT income_statement (annual, 2022-09-30) — Basic EPS: -1.27
ADNT cash_flow (annual, 2022-09-30) — Beginning Cash Position: 1521000000.00
ADNT balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 1053000000.00
ADNT cash_flow (annual, 2022-09-30) — Capital Expenditure: -227000000.00
ADNT cash_flow (annual, 2022-09-30) — Capital Expenditure Reported: -227000000.00
ADNT balance_sheet (annual, 2022-09-30) — Capital Stock: 0.00
ADNT balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 947000000.00
ADNT balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 947000000.00
ADNT cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: -1273000000.00